December 07, 2016 8:25 AM ET


Company Overview of Dermira, Inc.

Key Executives for Dermira, Inc.

NameBoard RelationshipsTitleAge
Thomas G. Wiggans 148 RelationshipsCo-Founder, Chairman and Chief Executive Officer64
Eugene Andrew Bauer M.D.69 RelationshipsCo-Founder, Chief Medical Officer, Director and Member of Science & Technology Committee74
Christopher M. Griffith No RelationshipsCo-Founder and Vice President of Corporate Development & Strategy40
Andrew L. Guggenhime 5 RelationshipsChief Financial Officer and Chief Operating Officer48
Christine R. Conroy Pharm. D.No RelationshipsSenior Vice President for Regulatory Affairs55
View More Key Executives

Dermira, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas G. Wiggans 148 RelationshipsDermira, Inc.64
Eugene Andrew Bauer M.D. 69 RelationshipsDermira, Inc.74
Frederick B. Craves Ph.D. 131 RelationshipsBay City Capital LLC70
Jake R. Nunn CFA 46 RelationshipsNew Enterprise Associates46
David Eric Cohen M.D., M.P.H 50 RelationshipsDermira, Inc.51
View All Board Members

Dermira, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Matthew K. Fust42 Relationships2 Executives
Compensation Committee Ph.D.Frederick B. Craves131 Relationships2 Executives
Nominating Committee CFAJake R. Nunn46 Relationships3 Executives
Corporate Governance Committee CFAJake R. Nunn46 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$465.0K
Total Value of Options
Compensation as of Fiscal Year
Dermira, Inc. CEO Compensation
Industry Average


Gedeon Richter Plc Appoints Gábor Orbán as Chief Operating Officer, Effective January 1, 2017
December 06, 2016 7:06 AM ET
Gedeon Richter Plc. Announces Board Changes
December 06, 2016 7:04 AM ET
Teva Pharmaceutical Industries Limited Announces Executive Changes
December 05, 2016 9:01 PM ET
Astrazeneca Pharma India Announces Executive Changes
December 03, 2016 11:30 AM ET
AstraZeneca Pharma India Appoints Greg Mueller as Additional Director
December 03, 2016 11:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dermira, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at